LAMPERTICO, PIETRO

LAMPERTICO, PIETRO  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 387 (tempo di esecuzione: 0.011 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 2018 E. DegasperiR. D'AmbrosioR. PerbelliniS. De NicolaP. Lampertico + Article (author) -
2-year effectiveness and safety of Tenofovir in 302 NUC-naive patients with chronic hepatitis B : a multicenter european study in clinical practive 2011 P. LamperticoM. Zuin + Article (author) -
2-year effectiveness and safety of tenofovir in 302 NUC-naive patients with chronic hepatitis B: a multicenter European study in clinical practice 2012 P. LamperticoM. ZuinM. Colombo + Article (author) -
3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients 2007 P. LamperticoM. ViganòE. ManentiM. IavaroneM. Colombo + Article (author) -
3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients 2007 P. LamperticoM. ViganòE. ManentiM. IavaroneM. Colombo + Article (author) -
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics 2023 Maria Paola AnolliPietro Lampertico + Article (author) -
A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B 2018 Lampertico, P + Article (author) -
A drug transporter gene polymorphism predicts renal tubular toxicity in patients with chronic hepatitis B on long-term adefovir and lamivudine combination 2010 P. LamperticoP. DongiovanniL. V. C. ValentiS. R. FargionM. Colombo + Article (author) -
A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2A in hepatitis B e antigen-negative chronic hepatitis B 2018 Lampertico, Pietro + Article (author) -
A global scientific strategy to cure hepatitis B 2019 Lampertico, Pietro + Article (author) -
A multicenter italian study of rescue Adefovir Dipivoxil therapy in Lamivudine resistant patients : a 2-year analysis of 604 patients 2005 Pietro Lampertico + Article (author) -
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C 2021 D'Ambrosio, RobertaPerbellini, RiccardoLombardi, AndreaLampertico, Pietro + Article (author) -
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D 2023 Lampertico P. + Article (author) -
A prospective study of peripheral blood alpha-fetoprotein messenger RNA in cirrhotic patients at risk of hepatocellular carcinoma 2003 M. IavaroneP. LamperticoE. Del NinnoA. ZanellaM. Colombo + Article (author) -
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum 1997 Lampertico P.Rumi M. G. + Article (author) -
A response guided approach to peginterferon alfa-2a therapy based on HBsAg levels at weeks 12 and 24 improves response rates in HBeAG-negative, genotype D chronic hepatitis B patients 2011 P. LamperticoM. ViganoS. R. FargionF. Facchetti + Article (author) -
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B 2018 Lampertico, P. + Article (author) -
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms 2019 Lampertico, PietroD’Ambrosio, RobertaRosso, Chiara + Article (author) -
Acute hepatitis following assumption of a herbal remedy 2008 M. ViganòP. LamperticoM. Colombo Article (author) -
Acute kidney injury and chronic kidney disease after liver transplant: A retrospective observational study 2021 Invernizzi, FedericaPorata, GiuliaFrontini, GiuliaRaffiotta, FrancescaDe Feo, TulliaAlfieri, Carlo MLampertico, PietroRossi, GiorgioMessa, Piergiorgio + Article (author) -